{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T17:07:35Z","timestamp":1794244055646,"version":"4.9.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"am","delay-in-days":354,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL174547"],"award-info":[{"award-number":["R01 HL174547"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UG3 DA056884"],"award-info":[{"award-number":["UG3 DA056884"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA061320"],"award-info":[{"award-number":["R01 DA061320"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21DA051723"],"award-info":[{"award-number":["R21DA051723"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 GM132046"],"award-info":[{"award-number":["T32 GM132046"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jpet.2025.103616","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T11:07:02Z","timestamp":1748344022000},"page":"103616","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Xylazine exacerbates fentanyl-induced respiratory depression and bradycardia"],"prefix":"10.1016","volume":"392","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2349-3613","authenticated-orcid":false,"given":"Catherine","family":"Demery","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6476-3506","authenticated-orcid":false,"given":"Sierra C.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica S.","family":"Levitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6560-2211","authenticated-orcid":false,"given":"Jessica P.","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1849-8316","authenticated-orcid":false,"given":"John R.","family":"Traynor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpet.2025.103616_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.110993","article-title":"Xylazine potentiates the lethal but not the rewarding effects of fentanyl in mice","volume":"253","author":"Acosta-Mares","year":"2023","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jpet.2025.103616_bib3","article-title":"Xylazine in the opioid epidemic: A systematic review of case reports and clinical implications","volume":"15","author":"Ayub","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.jpet.2025.103616_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1381073","article-title":"Fentanyl activates opposing opioid and non-opioid receptor systems that control breathing","volume":"15","author":"Baby","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jpet.2025.103616_bib5","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.52694","article-title":"Opioids depress breathing through two small brainstem sites","volume":"9","author":"Bachmutsky","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.jpet.2025.103616_bib6","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.67523","article-title":"Dual mechanisms of opioid-induced respiratory depression in the inspiratory rhythm-generating network","volume":"10","author":"Baertsch","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.jpet.2025.103616_bib7","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.81119","article-title":"Opioid suppression of an excitatory pontomedullary respiratory circuit by convergent mechanisms","volume":"12","author":"Bateman","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.jpet.2025.103616_bib8","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/bph.15580","article-title":"Understanding and countering opioid-induced respiratory depression","volume":"180","author":"Bateman","year":"2023","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jpet.2025.103616_bib9","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s00213-023-06390-y","article-title":"Xylazine effects on opioid-induced brain hypoxia","volume":"240","author":"Choi","year":"2023","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jpet.2025.103616_bib10","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/s41386-023-01782-2","article-title":"Combined treatment with naloxone and the alpha2 adrenoceptor antagonist atipamezole reversed brain hypoxia induced by a fentanyl-xylazine mixture in a rat model","volume":"49","author":"Choi","year":"2024","journal-title":"Neuropsychopharmacology"},{"issue":"Suppl 1","key":"10.1016\/j.jpet.2025.103616_bib11","first-page":"S39","article-title":"Of mice and men. When it comes to studying ageing and the means to slow it down, mice are not just small humans","author":"Demetrius","year":"2005","journal-title":"EMBO Rep 6 Spec No"},{"key":"10.1016\/j.jpet.2025.103616_bib14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.resp.2011.08.010","article-title":"Chemosensory control by commissural nucleus of the solitary tract in rats","volume":"179","author":"Favero","year":"2011","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1016\/j.jpet.2025.103616_bib15","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1152\/japplphysiol.01121.2001","article-title":"Noninvasive measurement of midexpiratory flow indicates bronchoconstriction in allergic rats","volume":"93","author":"Glaab","year":"2002","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/j.jpet.2025.103616_bib17","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1152\/japplphysiol.00819.2021","article-title":"Effects of fentanyl overdose-induced muscle rigidity and dexmedetomidine on respiratory mechanics and pulmonary gas exchange in sedated rats","volume":"132","author":"Haouzi","year":"2022","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/j.jpet.2025.103616_bib18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/15563650.2024.2309326","article-title":"Evaluation of the relationship of xylazine and fentanyl blood concentrations among fentanyl-associated fatalities","volume":"62","author":"Hays","year":"2024","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.jpet.2025.103616_bib19","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/bph.14860","article-title":"Fentanyl depression of respiration: Comparison with heroin and morphine","volume":"177","author":"Hill","year":"2020","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jpet.2025.103616_bib20","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.0572","article-title":"Knowledge, preference, and adverse effects of xylazine among adults in substance use treatment","volume":"7","author":"Hochheimer","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jpet.2025.103616_bib21","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/bph.15573","article-title":"The anomalous pharmacology of fentanyl","volume":"180","author":"Kelly","year":"2023","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jpet.2025.103616_bib22","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1037\/pha0000670","article-title":"Xylazine suppresses fentanyl consumption during self-administration and induces a unique sex-specific withdrawal syndrome that is not altered by naloxone in rats","volume":"32","author":"Khatri","year":"2024","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1016\/j.jpet.2025.103616_bib23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neuropharm.2019.02.008","article-title":"Respiratory depression and brain hypoxia induced by opioid drugs: Morphine, oxycodone, heroin, and fentanyl","volume":"151","author":"Kiyatkin","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jpet.2025.103616_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2024.1354722","article-title":"Brain oxygen responses induced by opioids: focus on heroin, fentanyl, and their adulterants","volume":"15","author":"Kiyatkin","year":"2024","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.jpet.2025.103616_bib25","doi-asserted-by":"crossref","first-page":"234","DOI":"10.5326\/15473317-34-3-234","article-title":"Comparison of sedative and cardiorespiratory effects of diazepam, acepromazine, and xylazine in ferrets","volume":"34","author":"Ko","year":"1998","journal-title":"J Am Anim Hosp Assoc"},{"key":"10.1016\/j.jpet.2025.103616_bib26","first-page":"22nr03473","article-title":"The appearance of xylazine in the United States as a fentanyl adulterant","volume":"25","author":"Leconte","year":"2023","journal-title":"Prim Care Companion CNS Disord"},{"key":"10.1016\/j.jpet.2025.103616_bib27","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1113\/JP270822","article-title":"\u03bc opioid receptor activation hyperpolarizes respiratory-controlling Kolliker-Fuse neurons and suppresses post-inspiratory drive","volume":"593","author":"Levitt","year":"2015","journal-title":"J Physiol"},{"key":"10.1016\/j.jpet.2025.103616_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-34047-w","article-title":"Locus coeruleus as a vigilance centre for active inspiration and expiration in rats","volume":"8","author":"Magalh\u00e3es","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jpet.2025.103616_bib29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1124\/jpet.122.001476","article-title":"Heroin- and fentanyl-induced respiratory depression in a rat plethysmography model: potency, tolerance, and sex differences","volume":"385","author":"Marchette","year":"2023","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpet.2025.103616_bib30","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/nn1517","article-title":"Sleep-disordered breathing after targeted ablation of preBotzinger complex neurons","volume":"8","author":"McKay","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.jpet.2025.103616_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131451","article-title":"New metrics for evaluating viral respiratory pathogenesis","volume":"10","author":"Menachery","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jpet.2025.103616_bib32","first-page":"121","article-title":"Effects of diazepam and xylazine on changes of blood oxygen and glucose levels in mice","volume":"6","author":"Mohammed","year":"2018","journal-title":"Adv Anim Vet Sci"},{"key":"10.1016\/j.jpet.2025.103616_bib33","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1471-2105-7-123","article-title":"Detecting outliers when fitting data with nonlinear regression\u2014a new method based on robust nonlinear regression and the false discovery rate","volume":"7","author":"Motulsky","year":"2006","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.jpet.2025.103616_bib34","unstructured":"National Research Council Committee (2011), Guide for the Care and Use of Laboratory Animals, National Academies Press, Washington (DC)."},{"key":"10.1016\/j.jpet.2025.103616_bib35","series-title":"Xylazine toxicity, in StatPearls [Internet]","author":"Papudesi","year":"2024"},{"key":"10.1016\/j.jpet.2025.103616_bib36","first-page":"170","article-title":"Mouse models of human disease: An evolutionary perspective","volume":"2016","author":"Perlman","year":"2016","journal-title":"Evol Med Public Health"},{"key":"10.1016\/j.jpet.2025.103616_bib37","series-title":"Hypercapnea, in StatPearls [Internet]","author":"Rawat","year":"2024"},{"issue":"Suppl 1","key":"10.1016\/j.jpet.2025.103616_bib38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40635-020-00307-1","article-title":"Pathophysiology and clinical consequences of arterial blood gases and pH after cardiac arrest","volume":"8","author":"Robba","year":"2020","journal-title":"Intensive Care Med Exp"},{"key":"10.1016\/j.jpet.2025.103616_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.forsciint.2014.03.015","article-title":"Xylazine intoxication in humans and its importance as an emerging adulterant in abused drugs: a comprehensive review of the literature","volume":"240","author":"Ruiz-Col\u00f3n","year":"2014","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.jpet.2025.103616_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109816","article-title":"Impacts of xylazine on fentanyl demand, body weight, and acute withdrawal in rats: a comparison to lofexidine","volume":"245","author":"Sadek","year":"2024","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jpet.2025.103616_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112571","article-title":"Nitrosyl factors play a vital role in the ventilatory depressant effects of fentanyl in unanesthetized rats","volume":"146","author":"Seckler","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jpet.2025.103616_bib42","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1152\/jn.00542.2014","article-title":"Peripheral chemoreceptors tune inspiratory drive via tonic expiratory neuron hubs in the medullary ventral respiratory column network","volume":"113","author":"Segers","year":"2015","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.jpet.2025.103616_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1280289","article-title":"\u201cTranq-dope\u201d overdose and mortality: lethality induced by fentanyl and xylazine","volume":"14","author":"Smith","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jpet.2025.103616_bib45","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.50613","article-title":"Opioids modulate an emergent rhythmogenic process to depress breathing","volume":"8","author":"Sun","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.jpet.2025.103616_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2024.124059","article-title":"A quantitative LC-MS\/MS analysis of xylazine, p-fluorofentanyl, fentanyl and fentanyl-related compounds in postmortem blood","volume":"1237","author":"Truver","year":"2024","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.jpet.2025.103616_bib47","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1538\/expanim.14-0050","article-title":"Vital signs monitoring during injectable and inhalant anesthesia in mice","volume":"64","author":"Tsukamoto","year":"2015","journal-title":"Exp Anim"},{"key":"10.1016\/j.jpet.2025.103616_bib48","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1113\/JP278612","article-title":"Differential impact of two critical respiratory centres in opioid-induced respiratory depression in awake mice","volume":"598","author":"Varga","year":"2020","journal-title":"J Physiol"},{"key":"10.1016\/j.jpet.2025.103616_bib49","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4103\/atm.ATM_215_19","article-title":"The correlation between oxygen saturation indices and the standard obstructive sleep apnea severity","volume":"15","author":"Wali","year":"2020","journal-title":"Ann Thorac Med"},{"key":"10.1016\/j.jpet.2025.103616_bib50","series-title":"West\u2019s Respiratory Physiology: The Essentials","author":"West","year":"2021"},{"key":"10.1016\/j.jpet.2025.103616_bib51","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2253-13-33","article-title":"Xylazine-induced reduction of tissue sensitivity to insulin leads to acute hyperglycemia in diabetic and normoglycemic monkeys","volume":"13","author":"Xiao","year":"2013","journal-title":"BMC Anesthesiol"},{"key":"10.1016\/j.jpet.2025.103616_bib52","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s11517-010-0674-2","article-title":"Sleep apnea monitoring and diagnosis based on pulse oximetry and tracheal sound signals","volume":"48","author":"Yadollahi","year":"2010","journal-title":"Med Biol Eng Comput"},{"key":"10.1016\/j.jpet.2025.103616_bib53","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.resp.2006.12.007","article-title":"Muscarinic receptors and alpha2-adrenoceptors interact to modulate the respiratory rhythm in mouse neonates","volume":"157","author":"Zanella","year":"2007","journal-title":"Respir Physiol Neurobiol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525398290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525398290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T10:13:19Z","timestamp":1753870399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356525398290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":48,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0022356525398290"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103616","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Xylazine exacerbates fentanyl-induced respiratory depression and bradycardia","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103616","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103616"}}